myxoinflammatory fibroblastic sarcoma

myxoinflammatory fibroblastic sarcoma

low-grade malignant tumor of subcutaneous soft tissues invading into the joints and tendons, composed of fibroblastic cells, often showing virallike inclusion in nuclei and large nucleoli, arranged in clusters of myxoid stroma and infiltrates of inflammatory cells.
References in periodicals archive ?
Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare soft tissue tumor first reported in 1998 by 3 independent investigators.
Myxoinflammatory fibroblastic sarcoma presents as a painless, slowly growing mass.
Myxoinflammatory fibroblastic sarcoma is a rare soft tissue sarcoma that tends to occur in the distal extremities in adults patients.
Myxoinflammatory fibroblastic sarcoma (MIES) is a rare, low-grade, malignant, soft-tissue tumor that typically affects the distal extremities of middle-aged patients.
Lucas, MD, reviews and updates myxoinflammatory fibroblastic sarcoma, a challenging soft tissue tumor that is frequently misdiagnosed by pathologists unaware of its clinicopathologic manifestations.
Myxoinflammatory fibroblastic sarcoma (MIFS) typically affects lower extremities.
Myxoinflammatory Fibroblastic Sarcoma (Also Called Inflammatory Myxohyaline Tumor of Distal Extremities).
Consistent t(1; 10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Spindle Cell Neoplasms and Their Differential Diagnoses Fibrohistiocytic and fibroblastic neoplasm Dermatofibrosarcoma protuberans and giant cell fibroblastoma Myxoinflammatory fibroblastic sarcoma Solitary fibrous tumor Giant cell angiofibroma Lipofibromatosis Fibroma Superficial angiomyxoma Superficial acral fibromyxoma Cellular digital fibroma Cellular angiofibroma Superficial [CD34.
Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare, malignant soft tissue neoplasm that was first described in 1997 by Montgomery, (1) with further nearsimultaneous descriptions the following year by Montgomery et al (2) (51 cases), Meis-Kindblom and Kindblo (m) 3 (44 cases), and Michal4 (5 cases).
Myxoinflammatory fibroblastic sarcoma is a rare neoplasm, with fewer than 200 cases reported.
Five cases of myxoinflammatory fibroblastic sarcoma were present in the IB group.